Taro’s generic version of UCB’s Keppra oral solution approved by FDA
ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of UCB’s Keppra oral solution, agency records show.
The FDA approved Taro Pharmaceutical Industries’ levetiracetam oral solution in the 100-mg-per-milliliter strength. The drug is used to treat epilepsy.
Keppra had sales of $1.3 billion in 2007, according to UCB financial data.
Kinney Drugs acquires independent Harbor Pharmacy
GOUVERNEUR, N.Y. An independent pharmacy has agreed to an acquisition by Kinney Drugs, Kinney announced Wednesday.
Harbor Pharmacy, at 34 Route 30 North in Bomoseen, Vt., will become a Kinney Drugs store starting Feb. 15, though pharmacist Dick Abel will remain there, and Kinney will allow the existing staff to remain as well. Abel has owned and operated Harbor Pharmacy for 24 years.
“Everyone at Kinney Drugs is excited to welcome Harbor Pharmacy employees and customers into our family,” Kinney chairman and CEO Craig Painter said in a statement. “It is important to us that this transition be as smooth as possible for both Harbor Pharmacy customers and their associates.”
Price Chopper creates widespread N.Y. network of immunizing pharmacies
SCHENECTADY, N.Y. Price Chopper has become the first pharmacy chain in New York to create a statewide network of immunizers in nearly every ZIP code, the Schenectady, N.Y.-based supermarket chain announced Wednesday.
The Schenectady, N.Y.-based supermarket chain will mark a new state law allowing pharmacists to perform immunizations by sponsoring a press event and flu clinic Friday at 11 a.m. at its store at 1879 Altamont Ave. in Schenectady. Company executives, including VP pharmacy Vincent Mainella and visitors such as Pharmacist Society of the State of New York executive director Craig Burridge will be present.
Every Price Chopper pharmacy will have a pharmacist who has completed the Centers for Disease Control and Prevention’s required 20-hour training program for delivering immunizations. Immunizations will be limited to adults 19 and older receiving flu and pneumonia vaccines.